Aging-associated Aberrant Mitochondrial Redox Signaling, Physical Activity, and Sarcopenia

Area of Science:

• Gerontology
• Mitochondrial Biology
• Skeletal Muscle Physiology

Background:

• Aging skeletal muscle is characterized by mitochondrial dysfunction, including altered morphology, reduced metabolic capacity, and impaired bioenergetics.
• Mitochondrial reactive oxygen species (ROS) play a crucial role in redox signaling, but their dysregulation in aged muscle contributes to dysfunction and potential apoptosis.
• The precise role of mitochondrial dysfunction in age-related muscle loss (sarcopenia) is debated, but aberrant redox signaling is increasingly recognized as central.

Purpose of the Study:

• To explore the intricate relationship between mitochondrial redox signaling and age-related muscle loss.
• To highlight the role of Nuclear factor erythroid 2-related factor 2 (Nrf2) in regulating antioxidant pathways within aging skeletal muscle.
• To identify potential non-pharmacological and pharmacological interventions for preventing sarcopenia.

Main Methods:

• Review of current scientific literature on mitochondrial function, redox signaling, and sarcopenia in aging.
• Analysis of the role of Nrf2 in antioxidant gene expression and its modulation.
• Consideration of exercise and Nrf2-modulating substances as therapeutic strategies.

Main Results:

• Mitochondrial bioenergetic impairment in aged muscle leads to excessive ROS production and defective mitochondria.
• Dysregulated redox signaling, influenced by Nrf2 pathways, is a key factor in age-related muscle atrophy.
• Both physical activity and Nrf2-modulating agents are emerging as promising interventions.

Conclusions:

• Understanding the link between redox signaling and sarcopenia is crucial for developing effective prevention strategies.
• Optimized exercise programs and Nrf2 signaling modulators offer innovative, non-pharmacological approaches to combat age-related muscle loss.
• Combined interventions targeting redox signaling may ameliorate sarcopenia and its associated frailty.